THE EFFECT OF N-FORMIMIDOYL THIENAMYCIN, CEFTAZIDIME, CEFOTIAM, CEFTRIAXONE AND CEFOTAXIME ON NONFERMENTATIVE GRAM-NEGATIVE RODS, AEROMONAS, PLESIOMONAS AND ENTEROBACTER AGGLOMERANS

被引:26
作者
VONGRAEVENITZ, A
BUCHER, C
机构
关键词
D O I
10.1007/BF01640878
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:293 / 298
页数:6
相关论文
共 29 条
[1]  
Anhalt J.P., 1980, MANUAL CLIN MICROBIO, P478
[2]  
APPELBAUM PC, 1981, 12TH INT C CHEM FLOR, P183
[3]   INVITRO EVALUATION OF LY127935 (6059S) COMPARED WITH CEFOTAXIME, 8 OTHER BETA-LACTAMS AND 2 AMINOGLYCOSIDES [J].
BARRY, AL ;
THORNSBERRY, C ;
JONES, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (06) :775-784
[4]   THE SUSCEPTIBILITY OF NOSOCOMIAL PATHOGENS TO CEFTAZIDIME [J].
BRUMFITT, W ;
HAMILTONMILLER, JMT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :15-21
[5]   INFLUENCE OF INOCULUM SIZE ON ACTIVITY OF CEFOPERAZONE, CEFOTAXIME, MOXALACTAM, PIPERACILLIN, AND N-FORMIMIDOYL THIENAMYCIN (MK0787) AGAINST PSEUDOMONAS-AERUGINOSA [J].
CORRADO, ML ;
LANDESMAN, SH ;
CHERUBIN, CE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) :893-896
[6]  
FASS RJ, 1980, REV INFECT DIS, V2, P841
[7]   ACTIVITY OF CEFTAZIDIME AGAINST PSEUDOMONAS-AERUGINOSA FROM BACTEREMIC AND FIBROCYSTIC PATIENTS [J].
FLEMING, PC ;
KNIE, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :169-173
[8]   CEFOTAXIME - INVITRO ACTIVITY AND TENTATIVE INTERPRETIVE STANDARDS FOR DISK SUSCEPTIBILITY TESTING [J].
FUCHS, PC ;
BARRY, AL ;
THORNSBERRY, C ;
JONES, RN ;
GAVAN, TL ;
GERLACH, EH ;
SOMMERS, HM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (01) :88-93
[9]  
Gavan T. L., 1980, MANUAL CLIN MICROBIO, P459
[10]   ACTIVITY OF CEFTAZIDIME (GR 20263) AGAINST NOSOCOMIALLY IMPORTANT PATHOGENS [J].
HAMILTONMILLER, JMT ;
BRUMFITT, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (06) :1067-1069